It follows that any restoration of p53 function could move cancer cells back toward normalcy on multiple fronts, including not only their response to traditional therapies (i.e., radiotherapy and chemotherapy) but also to immunotherapy based on ICIs. The gene discussed is TP53; the disease is cancer.